Mark J. Evans
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 12
- Cancer Cells and Metastasis 6
- Immunology top 5%
- Molecular Biology top 5%
- Mitochondrial Function and Pathology 6
- RNA Interference and Gene Delivery 5
- Cancer Research top 10%
- Genetics top 5%
- Estrogen and related hormone effects 9
-
- Cholesterol and Lipid Metabolism 13
-
- Effects of Radiation Exposure 13
-
- Hematopoietic Stem Cell Transplantation 6
- Co-authors
- Richard C. ScarpullaKehDih LaiDouglas C. HarnishC. J. KovacsHelen B. HartmanLouis A. MatisStephen P. SquintoRussell P. Rother
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Cell Proliferation (5 papers)Journal of Biological Chemistry (5 papers)Endocrinology (5 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Mark J. Evans
79 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 111
- Oncology 702
- Immunology 527
- Molecular Biology 1.5k
- Cancer Research 276
- Genetics 488
Countries citing papers authored by Mark J. Evans
This map shows the geographic impact of Mark J. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Evans more than expected).
Fields of papers citing papers by Mark J. Evans
This network shows the impact of papers produced by Mark J. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Evans. The network helps show where Mark J. Evans may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark J. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 122 | |
| 2 | 2009 | 79 | |
| 3 | 2009 | 82 | |
| 4 | Abstract 3619: A Novel Tissue Selective LXR Ligand, WYE-672 | 2008 | 1 |
| 5 | 2008 | 34 | |
| 6 | 2006 | 30 | |
| 7 | 2005 | 39 | |
| 8 | 2004 | 1 | |
| 9 | 2004 | 27 | |
| 10 | 2003 | 34 | |
| 11 | 2003 | 70 | |
| 12 | 2001 | 2 | |
| 13 | 1998 | 77 | |
| 14 | 1997 | 5 | |
| 15 | 1997 | 30 | |
| 16 | 1995 | 38 | |
| 17 | 1994 | 23 | |
| 18 | 1989 | 31 | |
| 19 | 1985 | 16 | |
| 20 | Limited exposure of rats to H(2)SO(4) with and without O3. | 1978 | 8 |
About Mark J. Evans
Mark J. Evans is a scholar working on Oncology, Cancer Research, Hematology, Radiology, Nuclear Medicine and Imaging and Radiation, having authored 79 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (13 papers), Effects of Radiation Exposure (13 papers), Drug Transport and Resistance Mechanisms (12 papers), Estrogen and related hormone effects (9 papers), Mitochondrial Function and Pathology (6 papers), Cancer Cells and Metastasis (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Oncology (702 citations), Immunology (527 citations), Molecular Biology (1.5k citations), Cancer Research (276 citations) and Genetics (488 citations). Mark J. Evans has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Richard C. Scarpulla, KehDih Lai, Douglas C. Harnish, C. J. Kovacs, Helen B. Hartman, Louis A. Matis, Stephen P. Squinto, Russell P. Rother, Scott A. Rollins and Shuguang Wang. Their work appears in journals such as Cell Proliferation, Journal of Biological Chemistry, Endocrinology, Bioorganic & Medicinal Chemistry Letters and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.